Target intelligence / Profile preview

Haptoglobin-related protein (HPR)

Target
HPR
Molecular classification
Other, Plasma protein, Hemoglobin-binding protein
01

Overview

Haptoglobin-related protein (HPR) is a plasma protein encoded by the HPR gene in humans, closely related to haptoglobin (HP). It binds hemoglobin with high affinity, forming complexes distinct from those of haptoglobin, and acts as a component of trypanosome lytic factor-1 (TLF-1) along with apolipoprotein L1, mediating innate immune protection against African trypanosomes (agents of sleeping sickness). HPR does not facilitate clearance of hemoglobin via the CD163 receptor as haptoglobin does, meaning its hemoglobin complex persists longer in the plasma. Elevated levels of HPR or its gene copy number may be protective against trypanosome infection and could serve as a biomarker for breast cancer recurrence risk. No approved drugs directly target HPR, and no direct therapeutic safety concerns are documented. HPR is primarily considered an innate immune mediator, rather than a receptor, enzyme, or transporter.

Other names
Haptoglobin-related proteinHPRA-259H10.2HPhaptoglobin-related proteinHaptoglobin-related locus
02

Mechanism of action

No drug mechanisms targeting HPR directly, but HPR—through TLF-1—contributes to trypanosome lysis in innate immunity.

03

Biological functions

Hemoglobin bindingClearance of cell-free hemoglobinHeme recyclingInnate immune responseComponent of trypanosome lytic factor (TLF-1)
04

Disease associations

Infection (notably human African trypanosomiasis/sleeping sickness)Cancer (recurrence prediction in breast cancer)Other (anhaptoglobinemia)
05

Biomarkers

Recurrence prediction in breast cancerresistance to sleeping sickness (as part of TLF-1 complex)

Beyond the preview

Go deeper on Haptoglobin-related protein (HPR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Haptoglobin-related protein (HPR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call